Journal of the Chinese Medical Association
Volume 69, Issue 4 , Pages 175-178 , April 2006

Nonalcoholic Fatty Liver Disease Manifesting Esophageal Variceal Bleeding

  • Chia-Pei Tang

      Affiliations

    • Division of Gastroenterology, Department of Medicine, Taipei, Taiwan, R.O.C.
  • ,
  • Yi-Shin Huang

      Affiliations

    • Division of Gastroenterology, Department of Medicine, Taipei, Taiwan, R.O.C.
    • Corresponding Author InformationCorrespondence to: Dr. Yi-Shin Huang, Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan, R.O.C.
  • ,
  • Shyh-Haw Tsay

      Affiliations

    • Department of Pathology, Taipei Veterans General Hospital, and National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.
  • ,
  • Full-Young Chang

      Affiliations

    • Division of Gastroenterology, Department of Medicine, Taipei, Taiwan, R.O.C.
  • ,
  • Shou-Dong Lee

      Affiliations

    • Division of Gastroenterology, Department of Medicine, Taipei, Taiwan, R.O.C.

Received 21 July 2005 ,Accepted 19 December 2005.

References 

  1. Neuschwander-Tetri BA , Caldwell SH . Nonalcoholic steatohepatitis: summary of an AASLD single topic conference . Hepatology . 2003;37:1202–1219
  2. Charlton M , Kasparova P . Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease . Liver Transpl . 2001;7:608–614
  3. Brunt EM . Nonalcoholic steatohepatitis . Semin Liver Dis . 2004;24:3–20
  4. Tsai WL , Yan CY . Impact of obesity on medical problems and quality of life in Taiwan . Am J Epidemiol . 2004;160:557–565
  5. World Health Organization  . The Asia-Pacific perspective: redefining obesity and its treatment . Geneva, Switzerland: World Health Organization; 2000;
  6. Lai SW , Tan CK . Epidemiology of fatty liver in a hospital-based study in Taiwan . South Med J . 2002;95:1288–1292
  7. Dixon JB , Bhathal PS , O'Brien PE . Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese . Gastroenterology . 2001;121:91–100
  8. Farrell GC . Drugs and steatohepatitis . Semin Liver Dis . 2002;22:185–194
  9. Sheth SG , Gordon FD , Chopa S . Nonalcoholic steatohepatitis . Ann Intern Med . 1997;126:136–145
  10. Youssef W , McCullough AJ . Diabetes mellitus, obesity, and hepatic steatosis . Semin Gastrointest Dis . 2002;13:17–30
  11. Wanless IR , Lentz JS . Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors . Hepatology . 1990;12:1106–1110
  12. Angulo P , Keach JC . Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis . Hepatology . 1999;30:1356–1362
  13. Brunt EM , Janney CG , Di Bisceglie AM , Neuschwander-Tetri BA , Bacon BR . Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions . Am J Gastroenterol . 1999;94:2467–2474
  14. Harrison SA , Neuschwander-Tetri BA . Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis . Clin Liver Dis . 2004;8:861–879
  15. Palmer M , Schaffner F . Effect of weight reduction on hepatic abnormalities in overweight patients . Gastroenterology . 1990;99:1408–1413

PII: S1726-4901(09)70201-1

doi: 10.1016/S1726-4901(09)70201-1

Journal of the Chinese Medical Association
Volume 69, Issue 4 , Pages 175-178 , April 2006